Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 41.16% is in line with its 3-year average of 39.07%, near the high end of its 3-year range (1.48%–43.77%).
As of the fiscal period ended Tuesday, June 30, 2026. 2.46% below its 12-month average of 42.20%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 41.16%.
DEBT TO ASSETS RATIO
41.16%
DEBT TO ASSETS RATIO AVG TTM
42.20%
DEBT TO ASSETS RATIO AVG 3Y
40.82%
DEBT TO ASSETS RATIO AVG 5Y
N/A
DEBT TO ASSETS RATIO AVG 10Y
N/A
DEBT TO ASSETS RATIO AVG 15Y
N/A
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-2.46%
CURRENT VS 3Y AVG
+0.83%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.29%
median of 100 covered companies
CURRENT VS SECTOR MEDIAN
+14342.71%
vs the sector median at left
Fortrea Holdings Inc.
Market Cap
$1.90B
Debt to Assets Ratio
41.16%
TTM Avg
42.20%
3Y Avg
40.82%
5Y Avg
N/A
Market Cap
$1.74B
Debt to Assets Ratio
0.44%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.71B
Debt to Assets Ratio
0.09%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.16B
Debt to Assets Ratio
0.05%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.52B
Debt to Assets Ratio
0.18%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.76B
Debt to Assets Ratio
0.59%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.00B
Debt to Assets Ratio
0.38%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Fortrea Holdings Inc. (FTRE) | $1.90B | 41.16% | 42.20% | 40.82% | N/A |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $1.74B | 0.44% | N/A | N/A | N/A |
| Intellia Therapeutics, Inc. (NTLA)vs › | $1.71B | 0.09% | N/A | N/A | N/A |
| Recursion Pharmaceuticals, Inc. (RXRX)vs › | $2.16B | 0.05% | N/A | N/A | N/A |
| Beam Therapeutics Inc. (BEAM)vs › | $2.52B | 0.18% | N/A | N/A | N/A |
| TransMedics Group, Inc. (TMDX)vs › | $2.76B | 0.59% | N/A | N/A | N/A |
| Teladoc Health, Inc. (TDOC)vs › | $1.00B | 0.38% | N/A | N/A | N/A |
| NeoGenomics, Inc. (NEO)vs › | $474.59M | 0.33% | N/A | N/A | N/A |
| NRC Health (NRC)vs › | $458.62M | 0.66% | N/A | N/A | N/A |
| Shoulder Innovations, Inc. (SI)vs › | $394.23M | 0.10% | N/A | N/A | N/A |
Debt/Assets
41.2%
Debt/Equity
2.13
Current Ratio
0.96
Interest Coverage
-0.3x
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 41.16% |
| 2026-03-31 | 41.66% |
| 2025-12-31 | 41.09% |
| 2025-09-30 | 43.30% |
| 2025-06-30 | 43.77% |
| 2025-03-31 | 41.21% |
| 2024-12-31 | 33.49% |
| 2024-09-30 | 32.86% |
| 2024-06-30 | 33.74% |
| 2024-03-31 | 39.84% |
| 2023-12-31 | 38.59% |
| 2023-09-30 | 39.06% |
| 2023-06-30 | 38.52% |
| 2023-03-31 | 38.63% |
| 2022-12-31 | 1.48% |
